Could a sticky patch replace the sugar drink test for cystic fibrosis diabetes?

NCT ID NCT06560463

Recruiting now Knowledge-focused Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study compares a continuous glucose monitor (CGM) worn on the skin to the standard oral glucose tolerance test (OGTT) for detecting diabetes in adults with cystic fibrosis. The OGTT is time-consuming and often skipped, so researchers want to see if the CGM is a simpler and equally effective alternative. Thirty adults with normal or mildly abnormal glucose tolerance will wear the CGM for 10 days and also undergo the standard test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could make diabetes screening for people with cystic fibrosis easier and more convenient, potentially improving early detection and health outcomes.
What could go wrong: This is a small, early-stage study with only 30 participants. The CGM may not be as accurate as the standard test, and results may not apply to all people with cystic fibrosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic fibrosis cystic fibrosis-related diabetes prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYSTIC FIBROSIS CYSTIC FIBROSIS RELATED DIABETES

Contacts and locations

Locations

The Medical College of Wisconsin
RECRUITING

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.